EVEREST ORGANICS
Back to Income Statement
|
EVEREST ORGANICS Last 5 Year Operating Profit History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹20 Cr | ₹7.19 Cr | ₹11 Cr | ₹0.93 Cr | ₹6.43 Cr |
What is the latest Operating Profit of EVEREST ORGANICS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹20 Cr |
| Mar2025 | ₹7.19 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹0.93 Cr |
| Mar2022 | ₹6.43 Cr |
How is Operating Profit of EVEREST ORGANICS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹20 Cr | 175.54 | |
| Mar2025 | ₹7.19 Cr | -34.56 | |
| Mar2024 | ₹11 Cr | 1,081.40 | |
| Mar2023 | ₹0.93 Cr | -85.53 | |
| Mar2022 | ₹6.43 Cr | - | |
Compare Operating Profit of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹219.5 Cr | -12.9% | -5.2% | -44.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -12.9% |
-5.2% |
-44.8% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses